Patents by Inventor Rita Raisman-Vozari

Rita Raisman-Vozari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRACYCLINE DERIVATIVES FOR TREATING NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES
    Publication number: 20230390309
    Abstract: The present invention relates to the field of medicine. In particular, it relates to the use of tetracycline derivatives in the treatment or prevention of a neurodegenerative or neuroinflammatory disease, such as Parkinson's disease.
    Type: Application
    Filed: October 14, 2021
    Publication date: December 7, 2023
    Inventors: BRUNO FIGADERE, RITA RAISMAN-VOZARI, PATRICK PIERRE MICHEL, LAURENT FERRIE, CLÉMENCE ROSE
  • 1, 4, 8-triazaphenanthrene derivatives for the treatment of neurodegenerative disorders
    Patent number: 10550115
    Abstract: The invention relates to compounds of formula (I), particularly for the use thereof as a medicament, especially in the treatment or prevention of neurogenerative disorders. The invention also relates to the methods for producing said compounds, and to the pharmaceutical compositions containing same.
    Type: Grant
    Filed: October 10, 2016
    Date of Patent: February 4, 2020
    Assignees: Institut Du Cerveau et de la Moëlle Epiniere, Centre National de la Recherche Scientifique (CNRS), Sorbonne Universite, Assistance Publique-Hopitaux de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paris-SUD
    Inventors: Bruno Figadere, Laurent Ferrie, Gael Le Douaron, Rita Raisman-Vozari, Patrick Michel, Julia Sepulveda
  • 1, 4, 8-Triazaphenanthrene Derivatives For The Treatment Of Neurodegenerative Disorders
    Publication number: 20190071438
    Abstract: The invention relates to compounds of formula (I), particularly for the use thereof as a medicament, especially in the treatment or prevention of neurogenerative disorders. The invention also relates to the methods for producing said compounds, and to the pharmaceutical compositions containing same.
    Type: Application
    Filed: October 10, 2016
    Publication date: March 7, 2019
    Applicants: Institut Du Cerveau et de la Moëlle Epiniere, Centre National de la Recherche Scientifique (CNRS (CNRS), Sorbonne Universite, Assistance Publique-Hopitaux de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paris-SUD
    Inventors: Bruno Figadere, Laurent Ferrie, Gael Le Douaron, Rita Raisman-Vozari, Patrick Michel, Julia Sepulveda
  • Aminoquinoxaline derivatives for treatment of neurodegenerative diseases
    Patent number: 9434701
    Abstract: The present invention relates to compounds of formula (I) below: for which: —X represents a hydrogen atom, a halogen atom, a group NO2 or NH2, —R0 represents H or —CH2—C?CH, and —R1 and R2 each represent, independently of one another, a hydrogen atom; a saturated or unsaturated, linear or branched hydrocarbon-based chain comprising from 1 to 10 carbon atoms; or an optionally substituted aryl group, and also the pharmaceutically acceptable salts thereof, the stereoisomers thereof or mixtures of stereoisomers thereof in any proportion, in particular for use thereof as a medicament, in particular in the treatment or prevention of neurodegenerative diseases, and also the processes for the preparation thereof and the pharmaceutical compositions comprising same.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: September 6, 2016
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE PARIS—SUD 11
    Inventors: Laurent Ferrie, Bruno Figadere, Gaël Le Douaron, Rita Raisman-Vozari, Fanny Schmidt
  • AMINOQUINOXALINE DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20140113903
    Abstract: The present invention relates to compounds of formula (I) below: for which: —X represents a hydrogen atom, a halogen atom, a group NO2 or NH2, —R0 represents H or —CH2—C?CH, and —R1 and R2 each represent, independently of one another, a hydrogen atom; a saturated or unsaturated, linear or branched hydrocarbon-based chain comprising from 1 to 10 carbon atoms; or an optionally substituted aryl group, and also the pharmaceutically acceptable salts thereof, the stereoisomers thereof or mixtures of stereoisomers thereof in any proportion, in particular for use thereof as a medicament, in particular in the treatment or prevention of neurodegenerative diseases, and also the processes for the preparation thereof and the pharmaceutical compositions comprising same.
    Type: Application
    Filed: March 30, 2012
    Publication date: April 24, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHESCIENTIFIQUE (CNRS), UNIVERSITE PARIS-SUD 11, UNIVERSITE PARIS-SUD 11
    Inventors: Laurent Ferrie, Bruno Figadere, Gaël Le Douaron, Rita Raisman-Vozari, Fanny Schmidt
  • Indole derivatives for treating neurodegenerative diseases
    Patent number: 8614246
    Abstract: The invention relates to a compound of the following formula (I), or to a pharmaceutically acceptable salt thereof or to a stereoisomer or mixture of stereoisomers at any proportions, where: X1 is a CH2 or C?O group; X2 is a linear saturated or unsaturated carbohydrate chain with 8 to 24 carbon atoms; R1 is a hydrogen atom or an OH or (C1-C6)alkoxy group such as methoxy; and R2 is a CH3 or CH2 OR3 group, with R3 being a hydrogen atom or a (C1-C6)alkyl, CO—(C1-C6)alkyl or NH—(C1-C6)alkyl group. The invention also relates to the use of said compound as a drug, in particular for treating neurodegenerative diseases, and to a method for preparing same.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: December 24, 2013
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Fanny Schmidt, Bruno Figadere, Rita Raisman-Vozari, Pierre Champy
  • INDOLE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES
    Publication number: 20110319387
    Abstract: The invention relates to a compound of the following formula (I), or to a pharmaceutically acceptable salt thereof or to a stereoisomer or mixture of stereoisomers at any proportions, where: X1 is a CH2 or C?O group; X2 is a linear saturated or unsaturated carbohydrate chain with 8 to 24 carbon atoms; R1 is a hydrogen atom or an OH or (C1-C6)alkoxy group such as methoxy; and R2 is a CH3 or CH2OR3 group, with R3 being a hydrogen atom or a (C1-C6)alkyl, CO—(C1-C6)alkyl or NH—(C1-C6)alkyl group. The invention also relates to the use of said compound as a drug, in particular for treating neurodegenerative diseases, and to a method for preparing same.
    Type: Application
    Filed: March 2, 2010
    Publication date: December 29, 2011
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Fanny Schmidt, Bruno Figadere, Rita Raisman-Vozari, Pierre Champy